Sheets Smith Wealth Management Has $764,000 Position in HealthEquity, Inc. (NASDAQ:HQY)

Sheets Smith Wealth Management boosted its holdings in shares of HealthEquity, Inc. (NASDAQ:HQY) by 3.5% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 7,965 shares of the company’s stock after acquiring an additional 273 shares during the period. Sheets Smith Wealth Management’s holdings in HealthEquity were worth $764,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Envestnet Asset Management Inc. grew its position in shares of HealthEquity by 7.1% during the 2nd quarter. Envestnet Asset Management Inc. now owns 115,614 shares of the company’s stock worth $9,966,000 after buying an additional 7,645 shares during the period. Renaissance Technologies LLC bought a new stake in HealthEquity in the second quarter valued at approximately $4,741,000. Vanguard Personalized Indexing Management LLC raised its holdings in HealthEquity by 8.8% in the second quarter. Vanguard Personalized Indexing Management LLC now owns 7,730 shares of the company’s stock worth $666,000 after purchasing an additional 626 shares during the period. Hsbc Holdings PLC boosted its position in shares of HealthEquity by 32.4% during the second quarter. Hsbc Holdings PLC now owns 91,969 shares of the company’s stock worth $7,932,000 after purchasing an additional 22,508 shares in the last quarter. Finally, Intech Investment Management LLC acquired a new position in shares of HealthEquity in the 2nd quarter valued at $1,138,000. Institutional investors own 99.55% of the company’s stock.

HealthEquity Price Performance

HealthEquity stock opened at $104.74 on Wednesday. The company has a market capitalization of $9.08 billion, a price-to-earnings ratio of 96.09, a PEG ratio of 1.80 and a beta of 0.54. The stock’s 50 day moving average is $99.04 and its 200-day moving average is $86.92. The company has a current ratio of 3.20, a quick ratio of 3.20 and a debt-to-equity ratio of 0.51. HealthEquity, Inc. has a 12 month low of $65.01 and a 12 month high of $105.82.

HealthEquity (NASDAQ:HQY) last released its quarterly earnings results on Monday, December 9th. The company reported $0.59 EPS for the quarter, missing analysts’ consensus estimates of $0.71 by ($0.12). HealthEquity had a return on equity of 9.70% and a net margin of 8.41%. During the same quarter in the prior year, the business earned $0.40 EPS. Equities research analysts expect that HealthEquity, Inc. will post 2.32 EPS for the current year.

Wall Street Analysts Forecast Growth

HQY has been the topic of several recent analyst reports. BTIG Research lifted their target price on HealthEquity from $110.00 to $130.00 and gave the stock a “buy” rating in a report on Thursday, November 14th. Bank of America boosted their price objective on HealthEquity from $100.00 to $120.00 and gave the company a “buy” rating in a research report on Wednesday, November 13th. Barrington Research lifted their price target on shares of HealthEquity from $105.00 to $120.00 and gave the company an “outperform” rating in a research note on Monday, December 2nd. The Goldman Sachs Group assumed coverage on shares of HealthEquity in a research report on Friday, November 15th. They set a “neutral” rating and a $108.00 price objective for the company. Finally, Mizuho began coverage on shares of HealthEquity in a research report on Wednesday, December 4th. They issued an “outperform” rating and a $126.00 price objective on the stock. One analyst has rated the stock with a hold rating and thirteen have given a buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $110.71.

Insider Activity at HealthEquity

In other news, Director Frank Corvino sold 1,039 shares of the business’s stock in a transaction on Wednesday, November 6th. The stock was sold at an average price of $96.10, for a total transaction of $99,847.90. Following the completion of the transaction, the director now owns 3,784 shares of the company’s stock, valued at approximately $363,642.40. The trade was a 21.54 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Robert W. Selander sold 8,250 shares of HealthEquity stock in a transaction that occurred on Monday, December 9th. The shares were sold at an average price of $101.56, for a total transaction of $837,870.00. Following the sale, the director now directly owns 66,469 shares in the company, valued at $6,750,591.64. This trade represents a 11.04 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 34,289 shares of company stock worth $3,355,718. Company insiders own 2.20% of the company’s stock.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.